Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Amounts presented in rows 5 through 9 consist of (i) 287,648 shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock") of Medline Inc., a Delaware corporation (the "Issuer") held by Mozart Holdco, Inc., a Delaware corporation ("Mozart Holdco") and (ii) 234,020,656 common units ("Common Units") of Medline Holdings, LP, a Delaware limited partnership and a direct subsidiary of the Issuer ("Medline Holdings") (paired with an equal number of shares of Class B common stock, par value $0.0001 per share ("Class B Common Stock") of the Issuer), which are exchangeable for shares of Class A Common Stock upon the corresponding cancellation of an equal number of shares of Class B Common Stock held by Mozart Holdco. The percentage presented in row 11 is calculated based on 811,418,179 shares of Class A Common Stock outstanding as of December 18, 2025, as reported in the Issuer's final prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025, following the underwriters' exercise in full of their option to purchase additional shares of Class A Common Stock, and assuming the exchange of 234,020,656 Common Units for 234,020,656 shares of Class A Common Stock and the corresponding cancellation of 234,020,656 shares of Class B Common Stock.


SCHEDULE 13G



 
Mozart Holdco, Inc.
 
Signature:/s/ James D. Abrams
Name/Title:James D. Abrams, Secretary
Date:02/13/2026